Ana Portelinha

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Chronic Lymphocytic Leukemia

Diffuse Large B Cell Lymphoma

Tyrosine Kinase

Endoplasmic Reticulum Stress

Top Venues

Nature communications

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ana Portelinha, Shenqiu Wang, Sara Parsa, Man Jiang, Alexander N Gorelick, Sagarajit Mohanty, Soumya Sharma, Elisa De Stanchina, Marjan Berishaj, Chunying Zhao, James Heward, Neeraj K Aryal, Omid Tavana, Jiayu Wen, Jude Fitzgibbon, Ahmet Dogan, Anas Younes, Ari M Melnick, Hans-Guido Wendel
SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphoma. The Journal of experimental medicine 221 (10) (2024)
Ana Portelinha, Shenqiu Wang, Sara Parsa, Man Jiang, Alexander N Gorelick, Sagarajit Mohanty, Soumya Sharma, Elisa De Stanchina, Marjan Berishaj, Chunying Zhao, James Heward, Neeraj K Aryal, Omid Tavana, Jiayu Wen, Jude Fitzgibbon, Ahmet Dogan, Anas Younes, Ari M Melnick, Hans-Guido Wendel
SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphoma. The Journal of experimental medicine 221 (10) (2024)
Ana Portelinha, Mariana da Silva Ferreira, Tatiana Erazo, Man Jiang, Zahra Asgari, Elisa de Stanchina, Anas Younes, Hans-Guido Wendel
Synthetic lethality of drug-induced polyploidy and BCL-2 inhibition in lymphoma. Nature communications 14 (1) (2023)
Ana Portelinha, Hans-Guido Wendel
The cat-and-mouse game of BTK inhibition. Blood 141 (13) (2023)
Ana Portelinha, Mariana da Silva Ferreira, Tatiana Erazo, Man Jiang, Zahra Asgari, Elisa de Stanchina, Anas Younes, Hans-Guido Wendel
Synthetic lethality of drug-induced polyploidy and BCL-2 inhibition in lymphoma. Nature communications 14 (1) (2023)
Ana Portelinha, Mariana da Silva Ferreira, Tatiana Erazo, Man Jiang, Zahra Asgari, Elisa de Stanchina, Anas Younes, Hans-Guido Wendel
Synthetic lethality of drug-induced polyploidy and BCL-2 inhibition in lymphoma. Nature communications 14 (1) (2023)